Cleveland Clinic Cancer Advances
Predicting Survival using Genomic Adjusted Radiation Dose
02 Feb 2023
Description
Jacob Scott, MD, DPhil, radiation oncologist, associate professor, and staff physician-scientist at Cleveland Clinic, joins the Cancer Advances podcast to talk about the research he presented at the American Society of Radiation Oncology (ASTRO) 2022 Annual Meeting. Listen as Dr. Scott discusses preliminary results from a recent Cleveland Clinic study about using GARD to predict overall survival in patients with HPV positive oropharyngeal squamous cell carcinoma treated with radiotherapy.
Audio
Featured in this Episode
No persons identified in this episode.
Transcription
No transcription available yet
Help us prioritize this episode for transcription by upvoting it.
0
upvotes
Popular episodes get transcribed faster